Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.34 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23639627 | 1.00 | TSHR (0.40) | TSHRPOLBMAPK1CYP3A4MAPT | |
| SCHEMBL2885967 | 1.00 | TSHR (0.40) | TSHRPOLBMAPK1CYP3A4MAPT | |
| SCHEMBL2885971 | 1.00 | TSHR (0.40) | TSHRPOLBMAPK1CYP3A4MAPT | |
| SCHEMBL2703747 | 1.00 | TSHR (0.40) | TSHRPOLBMAPK1CYP3A4MAPT | |
| SCHEMBL15483153 | 1.00 | TSHR (0.40) | TSHRPOLBMAPK1CYP3A4MAPT | |
| SCHEMBL1326381 | 0.92 | TSHR (0.43) | TSHRPOLBMAPK1CYP3A4MAPT | |
| SCHEMBL31310521 | 0.90 | POLB (0.35) | TSHRPOLBMAPK1CYP3A4 | |
| SCHEMBL30269695 | 0.85 | TSHR (0.36) | TSHRPOLBMAPK1CYP3A4MAPT | |
| SCHEMBL2854613 | 0.84 | TSHR (0.40) | TSHRPOLBMAPK1CYP3A4MAPT | |
| SCHEMBL1326384 | 0.84 | TSHR (0.40) | TSHRPOLBMAPK1CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8658743-B2 | Cage-shaped cyclopentanoic dianhydride, method for production thereof, and polyimide | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-02-25 | — | — | US | claimed |
| US-20120108759-A1 | CAGE-SHAPED CYCLOPENTANOIC DIANHYDRIDE, METHOD FOR PRODUCTION THEREOF, AND POLYIMIDE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-05-03 | — | — | US | claimed |
| US-8658743-B2 | Cage-shaped cyclopentanoic dianhydride, method for production thereof, and polyimide | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-02-25 | — | — | US | disclosed |
| US-20120108759-A1 | CAGE-SHAPED CYCLOPENTANOIC DIANHYDRIDE, METHOD FOR PRODUCTION THEREOF, AND POLYIMIDE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108759-A1 | CAGE-SHAPED CYCLOPENTANOIC DIANHYDRIDE, METHOD FOR PRODUCTION THEREOF, AND POLYIMIDE | DCUN1D4, DCUN1D1, AMD1 | TSHR 3630/4885POLB 962/4885MAPK1 3988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.